<p><strong>Hims &amp; Hers Health Inc.</strong> (NYSE: HIMS) 宣布计划通过 私募发行 提供 3 亿美元的可转换高级票据，到期时间为 2032 年。</p>
<p>此次融资可能加剧了投资者对潜在稀释和杠杆增加的担忧，给已经延续多日的股价下跌施加了压力。</p>
<h2>Hims &amp; Hers 发布 3 亿美元可转换票据发行计划</h2>
<p>该公司还预计将向初始购买者提供在发行后 13 天内购买额外 4500 万美元票据的选择权。</p>
<p>这家远程医疗公司表示，计划利用此次发行的收益来保持财务灵活性，同时推进其国际增长战略。</p>
<p>这包括支持拟议收购 <strong>Eucalyptus</strong>，预计将在 2026 年中期 完成。</p>
<p><strong>另请阅读：</strong>
<strong>Hims &amp; Hers 在激素治疗紧缺中定位自己为供应锚</strong></p>
<h2>公司瞄准人工智能和基础设施投资</h2>
<p>Hims &amp; Hers 还计划将部分收益用于技术和履约基础设施投资，旨在 提高运营效率。</p>
<p>该公司表示，额外的资金将有助于扩展旨在改善消费者体验和增强其闭环数据生态系统的人工智能能力。</p>
<p>部分收益还将用于与票据发行相关的 capped call 交易。这些交易通常旨在减少公司 A 类普通股的潜在稀释，如果 票据被转换。</p>
<h2>票据具有转换和赎回特性</h2>
<p>这些票据将是高级无担保债务，按半年利息计息，除非提前回购、赎回或转换，否则将于 2032 年 6 月 1 日到期。</p>
<p>持有人可以在特定条件下转换票据，Hims &amp; Hers 保留使用现金、A 类普通股或两者结合的方式进行转换的选择权。</p>
<p>该公司表示，可能会在 2029 年 6 月 6 日开始以现金赎回票据，需满足某些条件，包括公司股价在定义的时间段内超过转换价格的 130%。</p>
<p><strong>HIMS 股价动态：</strong> Hims &amp; Hers Health 的股票在周一发布时下跌 8.10%，报 23.02 美元， 根据 Benzinga Pro 数据。该股在过去一年中已下跌约 63%。</p>
<p><em>图片来源于 Shutterstock</em></p>

HIMS

2 倍做多 HIMS ETF - Defiance

<p>Hims & Hers Health Inc. 的股票在宣布进行 3 亿美元可转换债券发行后下跌了 8%，引发了投资者稀释的担忧。该公司计划将所得款项用于国际扩张、技术投资以及支持收购 Eucalyptus。这些债券将在 2032 年到期，并可能在特定条件下转换。HIMS 的股票在过去一年中大约下跌了 63%</p>

<p><strong>Hims &amp; Hers Health Inc.</strong> (NYSE: HIMS) announced plans to offer $300 million in convertible senior notes due 2032 through a private placement.</p>
<div class="lb-trans"><p><strong>Hims &amp; Hers Health Inc.</strong> (NYSE: HIMS) 宣布计划通过 私募发行 提供 3 亿美元的可转换高级票据，到期时间为 2032 年。</p>
</div><p>The capital raise has likely intensified investor concerns surrounding possible dilution and increased leverage, adding pressure to an already extended multi-session decline in the stock.</p>
<div class="lb-trans"><p>此次融资可能加剧了投资者对潜在稀释和杠杆增加的担忧，给已经延续多日的股价下跌施加了压力。</p>
</div><h2>Hims &amp; Hers Unveils $300 Million Convertible Notes Offering</h2>
<div class="lb-trans"><h2>Hims &amp; Hers 发布 3 亿美元可转换票据发行计划</h2>
</div><p>The company also expects to provide initial purchasers with an option to buy up to an additional $45 million in notes within 13 days of issuance.</p>
<div class="lb-trans"><p>该公司还预计将向初始购买者提供在发行后 13 天内购买额外 4500 万美元票据的选择权。</p>
</div><p>The telehealth company said it intends to use proceeds from the offering to maintain financial flexibility while advancing its international growth strategy.</p>
<div class="lb-trans"><p>这家远程医疗公司表示，计划利用此次发行的收益来保持财务灵活性，同时推进其国际增长战略。</p>
</div><p>That includes supporting the proposed acquisition of <strong>Eucalyptus</strong>, which is expected to close in mid-2026.</p>
<div class="lb-trans"><p>这包括支持拟议收购 <strong>Eucalyptus</strong>，预计将在 2026 年中期 完成。</p>
</div><p><strong>Read Also:</strong>
<strong>Hims &amp; Hers Positions Itself As Supply Anchor In Hormone Therapy Crunch</strong></p>
<div class="lb-trans"><p><strong>另请阅读：</strong>
<strong>Hims &amp; Hers 在激素治疗紧缺中定位自己为供应锚</strong></p>
</div><h2>Company Targets AI And Infrastructure Investments</h2>
<div class="lb-trans"><h2>公司瞄准人工智能和基础设施投资</h2>
</div><p>Hims &amp; Hers also plans to direct part of the proceeds toward technology and fulfillment infrastructure investments aimed at improving operational efficiency.</p>
<div class="lb-trans"><p>Hims &amp; Hers 还计划将部分收益用于技术和履约基础设施投资，旨在 提高运营效率。</p>
</div><p>The company said additional funding would help expand artificial intelligence capabilities designed to improve the consumer experience and strengthen its closed-loop data ecosystem.</p>
<div class="lb-trans"><p>该公司表示，额外的资金将有助于扩展旨在改善消费者体验和增强其闭环数据生态系统的人工智能能力。</p>
</div><p>A portion of the proceeds will also fund capped call transactions tied to the notes offering. Those transactions are generally intended to reduce potential dilution to the company’s Class A common stock if the notes are converted.</p>
<div class="lb-trans"><p>部分收益还将用于与票据发行相关的 capped call 交易。这些交易通常旨在减少公司 A 类普通股的潜在稀释，如果 票据被转换。</p>
</div><h2>Notes Carry Conversion And Redemption Features</h2>
<div class="lb-trans"><h2>票据具有转换和赎回特性</h2>
</div><p>The notes will be senior unsecured obligations accruing semi-annual interest and maturing on June 1, 2032, unless earlier repurchased, redeemed, or converted.</p>
<div class="lb-trans"><p>这些票据将是高级无担保债务，按半年利息计息，除非提前回购、赎回或转换，否则将于 2032 年 6 月 1 日到期。</p>
</div><p>Holders may convert the notes under specified conditions, with Hims &amp; Hers retaining the option to settle conversions using cash, shares of Class A common stock, or a combination of both.</p>
<div class="lb-trans"><p>持有人可以在特定条件下转换票据，Hims &amp; Hers 保留使用现金、A 类普通股或两者结合的方式进行转换的选择权。</p>
</div><p>The company said it may redeem the notes for cash beginning June 6, 2029, subject to certain conditions, including the company’s stock price exceeding 130% of the conversion price for a defined period.</p>
<div class="lb-trans"><p>该公司表示，可能会在 2029 年 6 月 6 日开始以现金赎回票据，需满足某些条件，包括公司股价在定义的时间段内超过转换价格的 130%。</p>
</div><p><strong>HIMS Price Action:</strong> Hims &amp; Hers Health shares were trading down 8.10% at $23.02 at the time of publication on Monday, according to Benzinga Pro data. The stock has declined about 63% over the past year.</p>
<div class="lb-trans"><p><strong>HIMS 股价动态：</strong> Hims &amp; Hers Health 的股票在周一发布时下跌 8.10%，报 23.02 美元， 根据 Benzinga Pro 数据。该股在过去一年中已下跌约 63%。</p>
</div><p><em>Photo via Shutterstock</em></p>
<div class="lb-trans"><p><em>图片来源于 Shutterstock</em></p>
</div>

为什么 Hims & Hers 的股票在周一下跌？